🚀 Medial Secures Investment on Shark Tank India - Fueling the Future of Professional Social Networking. 🔥
✕
Login
Home
News
Messages
Startup Showcase
Trackers
Premium
Premium Content
Jobs
Notifications
Settings
Try our Valuation Calculator →
Log In
News on Medial
KKR moves closer to sealing stake sale deal for JB Chemicals
VCCircle
·
1y ago
Medial
Global private equity firm KKR is nearing a deal to sell its stake in Indian pharmaceutical company JB Chemicals & Pharmaceuticals Ltd. After engaging in discussions with multiple potential buyers, KKR is now in advanced talks with a company for the sale of its stake. The Mumbai-listed JB Chemicals has been the subject of interest from various suitors.
View Source
Related News
Grapevine: KKR, JB Pharma, ONGC, Peak XV-backed Capillary, and Pernia in news
VCCircle
·
9m ago
Medial
KKR & Co. is exploring alternative monetization options after failing to reach a deal with private equity firms for the sale of its stake in JB Chemicals & Pharmaceuticals. Meanwhile, ONGC is considering a partnership with another state-owned unit to acquire Ayana Renewable Power. Additionally, Capillary, backed by Peak XV, and Pernia are also making headlines in the industry.
View Source
Grapevine: KKR mulls JB Pharma sale; Bharti eyes Del Monte JV exit
VCCircle
·
1y ago
Medial
Private equity firm KKR is considering selling its majority stake in JB Chemicals & Pharmaceuticals Ltd. KKR is reportedly hiring financial advisers to evaluate the potential sale. Meanwhile, Bharti Group is also exploring options to exit its joint venture with Del Monte, a fruit and vegetable processing company.
View Source
Exclusive: KKR changes tack to monetise JB Pharma bet as suitors balk at valuation ask
VCCircle
·
10m ago
Medial
Private equity firm KKR is exploring alternative options to monetize its investment in JB Chemicals & Pharmaceuticals Ltd, also known as JB Pharma. Talks to sell its stake in the drugmaker have hit a roadblock due to differences in valuation. KKR is now considering a multi-billion dollar plan to unlock the value of its investment in JB Pharma.
View Source
Grapevine: Zydus joins Torrent in race for JB Chemicals; The New Shop eyes 24Seven
VCCircle
·
1y ago
Medial
In the race to acquire JB Chemicals and Pharmaceuticals, Torrent Pharmaceuticals and Zydus Lifesciences are competing with private equity firm EQT. They have been shortlisted by KKR, the current owner of JB Chemicals. This comes after earlier reports of Torrent Pharma being in advanced talks to acquire KKR's stake in the company. Meanwhile, The New Shop is reportedly looking to acquire 24Seven.
View Source
KKR-controlled JB Chemicals inks deal to buy eyecare brands from Novartis
VCCircle
·
1y ago
Medial
Mumbai-based drugmaker JB Chemicals, majority-owned by KKR, has acquired a portfolio of ophthalmology brands from Novartis. The deal, valued at $116 million, includes a trademark license agreement and a three-year promotion and distribution agreement with Novartis. The acquisition will position JB Chemicals as the fourth-largest player in the ophthalmology therapy sector in India. The portfolio includes anti-infective, anti-allergy, and glaucoma drugs with a strong growth rate. This is another strategic acquisition for JB Chemicals, which has been expanding its portfolio through various deals in recent years.
View Source
KKR-controlled JB Chemicals draws interest from PE firms, drugmakers
VCCircle
·
1y ago
Medial
Several pharmaceutical companies and private equity firms are considering acquiring a majority stake in JB Chemicals & Pharmaceuticals Ltd, which is controlled by KKR & Co. The Mumbai-listed company has drawn interest from various suitors.
View Source
Torrent, JB Chemicals finalising steps for two-stage merger, combine may find place in pharma big 5
Economic Times
·
1m ago
Medial
Torrent Pharmaceuticals is pursuing a merger with JB Chemicals & Pharmaceuticals through a two-stage transaction. Initially, Torrent will acquire a 47.84% stake from KKR in JB Chemicals for approximately ₹13,433 crore. The second stage involves a merger to harness synergies, potentially placing the combined entity among India's top five pharma companies with a market capitalization of ₹1.41 lakh crore. This merger could enhance Torrent's portfolio with JB's domestic brands and a contract manufacturing business.
View Source
Zepto eyes capital raise; KKR in talks with Torrent for JB Pharma stake sale
VCCircle
·
1y ago
Medial
Quick commerce startup Zepto is reportedly in talks to raise over $300 million in funding from global investors to support its expansion plans. The Mumbai-based company, which currently has a valuation of $1.4 billion, aims to reach a valuation target of $2.5-3 billion. Zepto aims to achieve EBITDA positivity by September. In other news, private equity firm KKR is reportedly in discussions with Torrent Pharmaceuticals for a potential stake sale in JB Pharma.
View Source
KKR moves to fully monetize India infrastructure bet
VCCircle
·
7m ago
Medial
KKR moves to fully monetize India infrastructure bet Premium Credit: Reuters Private equity firm KKR has sold another chunk of its stake in an Indian operator of power transmission lines that it first backed more than five-and-a-half years ago, marking only its third liquidity move of the year in the country. KKR, which fully exited telecom tower operator Indus Towers Ltd in ......
View Source
Everstone set to exit Calibre Chemicals, appoints JP Morgan
Livemint
·
1y ago
Medial
Everstone Capital and the Ranjit Bhavnani family, founder-promoters of Calibre Chemicals, are planning to sell a combined 90% stake in the Mumbai-based specialty chemicals company. The deal is estimated to be worth around $200 million, or INR 1,500 crore. Everstone had acquired a controlling stake in Calibre Chemicals in 2021 for $100 million, and the company has since made several acquisitions to capitalize on the increasing demand for specialty chemicals. Calibre Chemicals' consolidated sales for FY23 stood at INR 1,013 crore, with a net profit of INR 131 crore. However, the company has faced challenges from increased competition and input cost volatility in the specialty chemicals sector.
View Source
Trackers
Active Indian VC’s
OG Capital
Email
With a hands-on approach, OG Capital aims to invest in over 20 promising...
Accel Partners
Email
Early and growth-stage investments in disruptive technology companies with...
Blume
Email
Early-stage venture capital firm investing in technology startups in India. Focus on...
Access All Trackers
Startup Showcase Winners
June 2025
Buddy
Helping your parents when you are miles away
BiteStop
The Pit Stop Your Cravings Deserve
Bloomer
The next generation E-commerce platform
Enter Ongoing Startup Showcase
Top Users
Trending News on Medial
Download the medial app to read full posts, comements and news.
Go to Medial App
Not Now
Know everything that’s happening in the startup ecosystem, first.
Enable Notifications?
No, thanks
Count me in
